tryn2,
Much of the big money is likely working with big pharma. Big pharma is making lots of money without DCvax in the picture. Once DCVax comes into the picture, price pressure will be on to reduce combo costs and place checkpoint inhibitors into their relative position at the table. The longer L takes to get approved the more big pharma makes as a stand alone or combo with each other and the longer it takes to get L and Direct in position to collectively dominate the market.
With enough nearer term media attention, especially in the UK, and obvious coming victories in the courts against manipulators later on then everything will change. Just know this, a new base line of support will be established with submission and that is expected by NWBO this month with unwanted and unexpected wiggle room granted until December in the previous PR. Not in their hands but very clear to those who have the documents what the expectations are. Best wishes.
News 
Market Data 
Discover 
AI
